Read More Pharma Industry News Clover Biopharmaceuticals stock in focus as new RSV re-vaccination data targets a gap GSK has not solved Clover Biopharmaceuticals says new RSV re-vaccination data beat Arexvy in older adults. Read what this could mean for the adult vaccine market. byVenkateshMarch 25, 2026